Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Squinto Stephen P
Relationship:   Director, 10% Owner
City:   Cheshire
State:   CT
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   238,160    

Indirect Shares

   6,290,493      
Direct Value   $19,437,710    

Indirect Value

   $19,013,945      
Total Shares   6,528,653      
Total Value   $38,451,655      


Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0 Alexion Pharmaceuticals Inc $19,437,710 Springworks Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Alexion Pharmaceuticals Inc ALXN EVP, Chief Global Ops.... 2014-10-27 106,508 2013-10-28 104,186    Premium*  
            Springworks Therapeutics, Inc. SWTX Director, 10% Owner 2022-05-19 131,652 2022-05-19 6,186,307    Premium*  
* Premium Members only  

Records found :    148         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-02-17 4 OE $11.92 $945,048 D/D 55,260 142,922 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-02-17 4 S $81.27 $4,495,938 D/D (55,260) 87,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-06-06 4 OE $17.65 $882,500 D/D 50,000 137,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-06-06 4 S $90.00 $4,500,000 D/D (50,000) 87,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-09 4 AS $100.34 $5,021,772 D/D (50,000) 87,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-09 4 OE $17.98 $899,000 D/D 50,000 137,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-27 4 OE $17.98 $2,096,280 D/D 100,000 187,662 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-27 4 AS $105.86 $10,800,149 D/D (100,668) 86,994 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research & Development   •       –      –    2012-07-31 4 AS $105.01 $106,585 D/D (1,015) 85,979 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research and Development   •       –      –    2011-02-02 4 A $0.00 $0 D/D 7,000 39,917 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research and Development   •       –      –    2011-02-17 4 GD $0.00 $0 D/D 280 39,637 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research and Development   •       –      –    2011-02-18 4 S $94.42 $944,200 D/D (10,000) 39,637 0 -
ALXN Alexion Pharmaceuticals I... EVP, Research and Development   •       –      –    2011-02-18 4 OE $20.58 $205,800 D/D 10,000 49,637 0 -
ALXN Alexion Pharmaceuticals I... Exec VP & Head of Research   •       –      –    2004-09-15 4 AS $17.50 $176,250 D/D (10,000) 23,601 -
ALXN Alexion Pharmaceuticals I... Exec VP & Head of Research   •       –      –    2004-09-15 4 OE $2.38 $43,047 D/D 18,125 31,726 -
ALXN Alexion Pharmaceuticals I... Exec VP, Head of Research   •       –      –    2003-12-31 4 A $17.35 $6,923 D/D 399 25,476 -
ALXN Alexion Pharmaceuticals I... Executive VP   •       –      –    2003-10-02 4 AS $20.01 $100,050 D/D (5,000) 30,077 -
ALXN Alexion Pharmaceuticals I... Executive VP& Head of Research   •       –      –    2004-08-16 4 S $15.30 $153,000 D/D (10,000) 15,476 -
ALXN Alexion Pharmaceuticals I... Executive VP& Head of Research   •       –      –    2004-08-16 4 OE $2.38 $43,047 D/D 18,125 23,601 -
ALXN Alexion Pharmaceuticals I... Executive VP/Head of Research   •       –      –    2003-12-02 4 AS $20.20 $101,000 D/D (5,000) 25,077 -
ALXN Alexion Pharmaceuticals I... Executive VP/Head of Research   •       –      –    2004-02-09 4 AS $20.58 $102,875 D/D (5,000) 20,476 -
ALXN Alexion Pharmaceuticals I... Executive VP/Head of Research   •       –      –    2004-05-10 4 AS $21.01 $105,050 D/D (5,000) 15,476 -
ALXN Alexion Pharmaceuticals I... officerTitle   •       –      –    2006-01-09 4 A $20.72 $82,880 D/D 4,000 8,000 -
  148  Records found
  1   2   3   4   5   6     
  Page 6 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us